SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Climb Bio, Inc.
@CLYM_InsiderForm 4 Filing: RA Capital Nexus Fund III, L.P. Acquires (Grant) shares of $CLYM
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Climb Bio, Inc.
Ticker: $CLYM
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-29
Shares: 70,284
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, RA Capital Nexus Fund III, L.P., holds the title of Director at Climb Bio, Inc..
On 2026-06-29, the insider transacted 70,284 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
RA Capital Nexus Fund III, L.P. (Director) was granted $0 of $CLYM
Post-Transaction Position: 70,284 shares
SEC Accession No: 0001231919-26-000722 (CIK: 1883840)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.